Keywords: GlaxoSmithKline, Finanical results, Fourth-quarter and full-year 2012

Difficult European conditions hit GlaxoSmithKline, whose 4th-qtr profits slumped

Article | 07 February 2013

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) blamed tough conditions in European markets for a decline in sales and profits for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in